Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer by Pattern of Metastatic Spread: ARCHES Post Hoc Analyses-Reference-Cited by-同舟云学术

Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer by Pattern of Metastatic Spread: ARCHES Post Hoc Analyses

Published:2021-05 Issue:5 Volume:205 Page:1361-1371
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Armstrong Andrew J.¹,Shore Neal D.²,Szmulewitz Russell Z.³,Petrylak Daniel P.⁴,Holzbeierlein Jeffrey⁵,Villers Arnauld⁶,Azad Arun⁷,Alcaraz Antonio⁸,Alekseev Boris⁹,Iguchi Taro¹⁰,Gomez-Veiga Francisco¹¹,Rosbrook Brad¹²,Lee Ho-Jin¹³,Haas Gabriel P.¹³,Stenzl Arnulf¹⁴

Affiliation:

1. Duke Cancer Institute Center for Prostate & Urologic Cancers, Durham, North Carolina

2. Carolina Urologic Research Center, Myrtle Beach, South Carolina

3. The University of Chicago, Chicago, Illinois

4. Yale Cancer Center, New Haven, Connecticut

5. The University of Kansas Medical Center, Kansas City, Kansas

6. University Hospital Centre, Lille University, Lille, France

7. Monash Health, Melbourne, Victoria, Australia

8. Hospital Clinic de Barcelona, Barcelona, Spain

9. Hertzen Moscow Cancer Research Institute, Moscow, Russia

10. Osaka City University Graduate School of Medicine, Osaka, Japan

11. Hospital Universitario de Salamanca, GITUR-IBSAL, Salamanca, Spain